Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection

Authors: Chansavath Phetsouphanh, David R. Darley, Daniel B. Wilson, Annett Howe, C. Mee Ling Munier, Sheila K. Patel, Jennifer A. Juno, Louise M. Burrell, Stephen J. Kent, Gregory J. Dore, Anthony D. Kelleher & Gail V. Matthews  Nature Immunology volume 23, pages210–216 (2022) June 30,…[...]

Read More

Self-reported outcomes, choices and discrimination among a global COVID-19 unvaccinated cohort

Authors: Robert Verkerk PhD1, Christof Plothe DO2, Naseeba Kathrada MBChB3 andKatarina Lindley DO4, Science Unit, Alliance for Natural Health International, 78 Dorking Road, Chilworth, Surrey, GU4 8NS, United Kingdom, Praxis…[...]

Read More

Clinical update on risks and efficacy of anti-SARS-CoV-2 vaccines in patients with autoimmune hepatitis and summary of reports on post-vaccination liver injury

Authors: Ana Lleo 1, Nora Cazzagon 2, Cristina Rigamonti 3, Giuseppe Cabibbo 4, Quirino Lai 5, Luigi Muratori 6, Marco Carbone 7, Italian Association for the Study of the LiverAffiliations expand PMID: 35410851 PMCID: PMC8958090DOI: 10.1016/j.dld.2022.03.014 Published:March 27, 2022DOI:https://doi.org/10.1016/j.dld.2022.03.014 Abstract Patients with liver diseases, especially those with cirrhosis,…[...]

Read More